{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:23Z","timestamp":1707524963689},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,2]]},"DOI":"10.7759\/cureus.37032","type":"journal-article","created":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T15:51:02Z","timestamp":1680450662000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics of SARS-CoV-2 Omicron Cases in Pune, Maharashtra, India"],"prefix":"10.7759","author":[{"given":"Rohidas","family":"Borse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh P","family":"Karyakarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmita","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Yanamandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshal","family":"Bhitkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Mundhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhananjay","family":"Ogale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagnath","family":"Radewad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvarna","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishanpal","family":"Karmodiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Classification of Omicron (B.1.1.529). SARS-CoV-2 Variant of Concern. World Health Organization. (2021). Accessed: 7th December 2022: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern ."},{"key":"ref2","unstructured":"Enhancing response to Omicron SARS-CoV-2 variant. Technical brief and priority actions for Member States. World Health Organization. (2022). Accessed: 7th December 2022: https:\/\/www.who.int\/publications\/m\/item\/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-acti...."},{"key":"ref3","unstructured":"COVID-19 Weekly Epidemiological Update. 106th ed. World Health Organization. (2022). Accessed. 7th December 2022: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---24-august-2022."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112816","article-title":"Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic","volume":"209","author":"Khandia R","year":"2022","unstructured":"Khandia R, Singhal S, Alqahtani T, et al.. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res. 2022, 209:112816. 10.1016\/j.envres.2022.112816","journal-title":"Environ Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.07.005","article-title":"Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands","volume":"122","author":"Petersen MS","year":"2022","unstructured":"Petersen MS, \u00cd Kongsstovu S, Eliasen EH, et al.. Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands. Int J Infect Dis. 2022, 122:636-43. 10.1016\/j.ijid.2022.07.005","journal-title":"Int J Infect Dis"},{"key":"ref6","unstructured":"INSACOG Weekly Bulletin No. 29. Department of Biotechnology. (2022). Accessed. 7th December 2022: https:\/\/dbtindia.gov.in\/sites\/default\/files\/INSACOG%20WEEKLY%20BULLETIN%2010-01-2022.pdf ."},{"key":"ref7","unstructured":"Coronavirus Pandemic (COVID-19). Our World in Data. (2022). Accessed. 25th August 2022: https:\/\/ourworldindata.org\/covid-vaccinations?country=IND."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.912367","article-title":"Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2","volume":"9","author":"Zhang J","year":"2022","unstructured":"Zhang J, Chen N, Zhao D, Zhang J, Hu Z, Tao Z. Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2. Front Med (Lausanne). 2022, 9:912367. 10.3389\/fmed.2022.912367","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00114-0","article-title":"Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study","volume":"10","author":"Jassat W","year":"2022","unstructured":"Jassat W, Abdool Karim SS, Mudara C, et al.. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. Lancet Glob Health. 2022, 10:e961-9. 10.1016\/S2214-109X(22)00114-0","journal-title":"Lancet Glob Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves","volume":"327","author":"Maslo C","year":"2022","unstructured":"Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves. JAMA. 2022, 327:583-4. 10.1001\/jama.2021.24868","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter N","year":"2022","unstructured":"Wolter N, Jassat W, Walaza S, et al.. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022, 399:437-46. 10.1016\/S0140-6736(22)00017-4","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7106e2","article-title":"Clinical characteristics and outcomes among adults hospitalised with laboratory-confirmed SARS-CoV-2 infection during periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant predominance \u2014 one hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022","volume":"71","author":"Modes ME","year":"2022","unstructured":"Modes ME, Directo MP, Melgar M, et al.. Clinical characteristics and outcomes among adults hospitalised with laboratory-confirmed SARS-CoV-2 infection during periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant predominance \u2014 one hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:217-23. 10.15585\/mmwr.mm7106e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27613","article-title":"Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021","volume":"94","author":"Houhamdi L","year":"2022","unstructured":"Houhamdi L, Gautret P, Hoang VT, Fournier PE, Colson P, Raoult D. Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021. J Med Virol. 2022, 94:2290-5. 10.1002\/jmv.27613","journal-title":"J Med Virol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e31","article-title":"Clinical characteristics of 40 patients infected with the SARS-CoV-2 Omicron variant in Korea","volume":"37","author":"Kim MK","year":"2022","unstructured":"Kim MK, Lee B, Choi YY, et al.. Clinical characteristics of 40 patients infected with the SARS-CoV-2 Omicron variant in Korea. J Korean Med Sci. 2022, 37:e31. 10.3346\/jkms.2022.37.e31","journal-title":"J Korean Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13762","article-title":"Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan","volume":"10","author":"Suzuki K","year":"2022","unstructured":"Suzuki K, Ichikawa T, Suzuki S, Tanino Y, Kakinoki Y. Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan. PeerJ. 2022, 10:e13762. 10.7717\/peerj.13762","journal-title":"PeerJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui KP","year":"2022","unstructured":"Hui KP, Ho JC, Cheung MC, et al.. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022, 603:715-20. 10.1038\/s41586-022-04479-6","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00852-5","article-title":"SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance","volume":"6","author":"Zhang X","year":"2021","unstructured":"Zhang X, Wu S, Wu B, et al.. SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance. Signal Transduct Target Ther. 2021, 6:430. 10.1038\/s41392-021-00852-5","journal-title":"Signal Transduct Target Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas D","year":"2021","unstructured":"Planas D, Veyer D, Baidaliuk A, et al.. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021, 596:276-80. 10.1038\/s41586-021-03777-9","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02844-0","article-title":"Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum","volume":"399","author":"Dejnirattisai W","year":"2022","unstructured":"Dejnirattisai W, Shaw RH, Supasa P, et al.. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet. 2022, 399:234-6. 10.1016\/S0140-6736(21)02844-0","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1041","article-title":"Neutralization of severe acute respiratory syndrome coronavirus 2 Omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients","volume":"75","author":"Lu L","year":"2022","unstructured":"Lu L, Mok BW, Chen LL, et al.. Neutralization of severe acute respiratory syndrome coronavirus 2 Omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients. Clin Infect Dis. 2022, 75:e822-6. 10.1093\/cid\/ciab1041","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00559-2","article-title":"Omicron variant and booster COVID-19 vaccines","volume":"10","author":"Burki TK","year":"2022","unstructured":"Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022, 10:e17. 10.1016\/S2213-2600(21)00559-2","journal-title":"Lancet Respir Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor PC","year":"2021","unstructured":"Taylor PC, Adams AC, Hufford MM, de la Torre I, Winthrop K, Gottlieb RL. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol. 2021, 21:382-93. 10.1038\/s41577-021-00542-x","journal-title":"Nat Rev Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.2022440","article-title":"Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost","volume":"11","author":"Ai J","year":"2022","unstructured":"Ai J, Zhang H, Zhang Y, et al.. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg Microbes Infect. 2022, 11:337-43. 10.1080\/22221751.2021.2022440","journal-title":"Emerg Microbes Infect"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.029","article-title":"T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals","volume":"185","author":"Naranbhai V","year":"2022","unstructured":"Naranbhai V, Nathan A, Kaseke C, et al.. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 2022, 185:1041-1051.e6. 10.1016\/j.cell.2022.01.029","journal-title":"Cell"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29837","article-title":"A Hitchhiker\u2019s Guide to worldwide COVID-19 vaccinations: a detailed review of monovalent and bivalent vaccine schedules, COVID-19 vaccine side effects, and effectiveness against Omicron and Delta variants","volume":"14","author":"Goyal L","year":"2022","unstructured":"Goyal L, Zapata M, Ajmera K, Chaurasia P, Pandit R, Pandit T. A Hitchhiker\u2019s Guide to worldwide COVID-19 vaccinations: a detailed review of monovalent and bivalent vaccine schedules, COVID-19 vaccine side effects, and effectiveness against Omicron and Delta variants. Cureus. 2022, 14:e29837. 10.7759\/cureus.29837","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146478-clinical-characteristics-of-sars-cov-2-omicron-cases-in-pune-maharashtra-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:48Z","timestamp":1707508788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146478-clinical-characteristics-of-sars-cov-2-omicron-cases-in-pune-maharashtra-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,2]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.37032","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,2]]}}}